ISTA's pipeline

From ISTA's 2011 results report (reported Feb 23, 2012):

Also during the fourth quarter, the Company announced that based on the results of clinical trials in dry eye, the Company plans to launch its first over-the-counter (OTC) artificial tear product in the second half of 2012. Clinical trials conducted in 2011 showed that ISTA's OTC tear product was highly effective in treating both the signs and symptoms of dry eye disease as compared to patient baseline.